INTRODUCTION
============

Magnetic resonance angiography (MRA) has developed dramatically over the last quarter century, and has played a particularly important role as a diagnostic tool for conditions of main intracranial arteries, including cerebral aneurysm[@B1] and arterial steno-occlusive disease[@B2] among others. The greatest benefit of MRA is its minimal invasiveness, namely its ability to precisely delineate intracranial arteries without puncture of the artery or administration of contrast media.

In patients with a stenosis of middle cerebral artery (MCA), visualization of MCA on MRA by using three dimensional (3D)-time of flight (TOF) technique has been reported to be associated with stroke recurrence[@B3] and the distal/proximal signal intensity ratio of the MCA stenosis is also shown to predict stroke risk,[@B4] indicating that signal intensity of intracranial arteries has a profound relation with stroke occurrence: Signal intensity loss of intracranial arteries on TOF-MRA signifies relevant arterial occlusion, which is considered to be a critical situation in terms of cerebral blood flow (CBF) and metabolism. Occasionally, however, limited number of cases without signal intensity of MCA on TOF-MRA are encountered: They show anterograde delineation on angiography using contrast media, such as CT angiography (CTA) or conventional angiography. Although this likely attributes to reduced arterial flow velocity,[@B5] a conclusive understanding has yet to be obtained.

Here, we evaluated the association between visualization of MCA on TOF-MRA or CTA and cerebrovascular conditions using single photon emission tomography (SPECT).

MATERIALS AND METHODS
=====================

Seventeen patients suspected of having occlusion of MCA or internal cerebral artery (ICA) on TOF-MRA were enrolled. As for ICA occlusion, because it was diagnosed with TOF-MRA, an occlusion at the intracranial portion of ICA was selected and all cases with ICA occlusion revealed no or misery flow of ICA from carotid bifurcation in the neck level. All patients underwent CTA and quantitative CBF examination. Although both symptomatic and asymptomatic cases were included, CBF examination was performed more than one month after onset to exclude fluctuation in CBF values, particularly in symptomatic cases. Furthermore, no cases showed recanalization of ICA and MCA on TOF-MRA performed one month after the onset or first examination.

Six of 17 cases had a normal MCA signal in the lesion side due to feeding by collateral supply and revealed ICA occlusion and ipsilateral MCA fed by anterior or posterior communicating artery. On the other hand, the remaining 11 cases had a signal loss of MCA on TOF-MRA, whereas CTA could delineate the anterograde delineation of MCA in 6 cases, but not in remaining 5 cases. We categorized all cases into three groups according to their visualization on TOF-MRA and CTA: group A had a MCA signal on TOF-MRA and an anterograde MCA delineation on CTA ([Fig. 1A and B](#F1){ref-type="fig"}); group B had no MCA signal and a MCA delineation on CTA ([Fig. 1C and D](#F1){ref-type="fig"}); and group C had both no signal and delineation of MCA on both modalities ([Fig. 1E and F](#F2){ref-type="fig"}). Resting CBF and CBF obtained after acetazolamide administration were measured in all groups, and cerebrovascular reactivity (CVR) was calculated. Case summary is presented in [Table 1](#T1){ref-type="table"}, showing mean age of 69.7±6.9 years old, male to female ratio of 8:9, and only 5 cases of symptomatic cases due to acute infarction.

TOF-MRA was conducted with a 3 tesla MRI (SIGNA HDxt: GE Healthcare, Connecticut, UK) and performed with the following sequence parameters: repetition time/echo time=26.0/2.7 msec; scan time, 239 seconds; section thickness, 1.2 mm; flip angle, 20°; field of view, 210×210; matrix, 512×224; and voxel volume, 0.43 mm^3^.

CTA was performed with a 64-row CT (LightSpeed VCT; GE Healthcare). After a bolus injection (50 mL) of iodine contrast media (300 mg/mL), helical CT scanning was performed using the Smart prep procedure, where the scanning was started after CT value at the carotid level reached sufficient level. All row data were calculated on the console CT system and transferred to the workstation to create clear 3D-CTA images.

CBF analysis was performed with a SPECT system (Infinia3; GE Healthcare). Quantitative CBF studies were acquired by N-isopropyl ^123^I P-iodoamphetamine (IMP) SPECT with the dual table autoradiography procedure,[@B6] in which the Quantitative SPECT package (Nihon Medi-Physics, Tokyo, Japan) was used for calculation of CBF (mL/100 g/min) at rest (rCBF) and after acetazolamide administration (aCBF). On two slices acquired by QSPECT which included the main areas of the MCA, the mean value between them was used as a CBF value in the MCA area, and CVR was calculated using this formula: CVR=(aCBF-rCBF)/rCBF (%).

CBF values and CVR were compared among groups using the analysis of variance (ANOVA) followed by post hoc analysis (Bonferroni correction), and unpaired Student\'s t-test was applied in comparison between rCBF and aCBF of each group. All analyses were conducted using IBM SPSS statistics software (version 21, IBM Corp., Armonk, NY, USA). A *p*\<0.05 was considered statistically significant.

Written informed consent for all procedures was obtained from all participants. This cross-sectional investigation was approved by the Ethics Committee of the Ehime University Graduate School of Medicine IRB (2017040401). All studies were performed in accordance with relevant guidelines and regulations.

RESULTS
=======

CBF maps after acetazolamide administration in each group, which correspond to cases in [Fig. 1](#F1){ref-type="fig"}, are shown in [Fig. 2](#F2){ref-type="fig"}. The figure shows that both group A and C have almost sufficient vascular response, whereas group B has miserable response in terms of CVR.

Mean rCBF values were 30.8±3.7 mL/100 g/min in group A, 32.4±7.0 in group B, and 39.1±11.7 in group C, with no significant difference among them ([Fig. 3](#F3){ref-type="fig"}, left), while mean aCBF values were 39.3±9.1, 25.4±5.7, and 50.0±23.4 mL/100 g/min, respectively ([Fig. 3](#F3){ref-type="fig"}, right) with no significant difference among them by using ANOVA. Meanwhile, evaluation of CBF changes before and after acetazolamide administration showed a significant reduction in aCBF compared with rCBF in group B only (*p*\<0.05), with the other two groups showing no significant changes between stages.

With regard to the analysis of CVR, mean CVR was 36.4±21.7% in group A, -19.7±18.1% in group B, and 21.4±35.2% in group C, respectively, and ANOVA revealed a significant difference among 3 groups, with differences being significant between groups A and B (*p*\<0.01). CVR was negative only in group B, showing the steal phenomenon in other words ([Fig. 4](#F4){ref-type="fig"}).

DISCUSSION
==========

In this study, we found various patterns in the visualization of the MCA on TOF-MRA and CTA. Among these, our group B, which had no MCA flow on TOF-MRA but ordinary MCA delineation on CTA, represented a critical condition in terms of cerebrovascular dynamics, and group C, which had no MCA flow on TOF-MRA and no MCA delineation on CTA, was also suspeted to be in a severe CBF condition. However, among 5 cases of group C there was only one case of infarction, implying that these cases might have developed a collateral flow like a leptomeningeal anastomosis for longer period, to maintain CBF equilibrium.

Attenuation of signal intensity in the cerebral main artery on TOF-MRA is generally regarded to be due to reduced arterial flow velocity in that vessel.[@B5] Although several causes of artifacts causing signal defects have been documented, such as flow turbulence, it seems quite likely that the invisible flow in the long course of the main artery is closely associated with slow flow velocity. Furthermore, Liebeskind, et al.[@B4] suggested the correlation of signal intensity ratio of distal/proximal MCA stenosis with stroke risk, which might be partly attributable to the slow flow in the stenotic lesion.

Hirooka, et al.[@B7] showed that grading of the visualization of MCA signal on single slab TOF-MRA was significantly correlated with the CVR in the cerebral hemispheres. Our six cases in group B are similar to the grade D used in their study. Given their conclusion and data in the above study, the loss of flow signal on TOF-MRA may reflect a reduced CVR, and the steal phenomenon in particular.

Since most of our cases were in subacute and chronic occlusion of the ICA or MCA, i.e. cases with infarction were 5/17 (29.4%), it is highly likely that either or both collateral and cross flow had consistently developed, and that hemispherical CBF had thereby reached a steady state. A previous study on symptomatic cases with unilateral occlusion of the ICA demonstrated the presence of regional CBF fluctuation and a significant difference in CBF value, depending on the direction of collateral flow, such as anterior or posterior.[@B8] Symptomatic cases with an intensely reduced CBF, CVR, or both require external and internal carotid artery bypass. Accordingly, therefore, the next step in our research is to apply this method to patients with acute stroke having major cerebral artery occlusion. Among less invasive methods for the evaluation of collateral flow in patients with unilateral ICA occlusion, the combination of two-dimensional-MRA and transcranial Doppler ultrasound appears to be a good diagnostic tool as conventional angiography,[@B9] and combination of multiple modalities would allow the assessment of not only CBF and CVR but also a collateral flow in the acute stage.

Regarding the effect of aging on the visibility of intracranial arteries on MRA, Kusunoki, et al.[@B10] reported that the visibility of cerebral main arteries, which are categorized as ICA, MCA (M1 segment), and distal MCA, was significantly reduced in an age-dependent manner, suggesting that our present results require validation in a wider range of cases to exclude age-related factors.

As an advanced procedure for the delineation of the cerebral main arteries, contrast enhanced 3D-TOF MRA is a promising tool. Comparison of pre- and postcontrast MRA appears to be able to detect pseudo-occlusion cases in the acute phase of occlusion of a cerebral main artery.[@B11] The addition of this contrast MRA after plain TOF-MRA might allow to differentiate cases with severely impacted cerebral dynamics even in the acute stage of a major arterial occlusion.

In conclusion, albeit there is a limitation of small number of cases, this study has shown that the visualization of the cerebral main artery on TOF-MRA may be closely associated with CVR, and it is quite possible that a pattern showing no MCA signal intensity on TOF-MRA but with MCA delineation on CTA indicates a dangerous situation in terms of cerebrovascular dynamics.
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![Categorized 3 groups corresponding to their visualization on TOF-MRA (A, C, and E) and CTA (B, D, and F) are shown. Group A (A and B) had a MCA signal on TOF-MRA (arrow) and an anterograde MCA delineation on CTA (arrowhead); group B (C and D) had no MCA signal (arrow) and MCA delineation (arrowhead); and group C (E and F) had no MCA signal (arrow) and no MCA delineation (arrowhead) on both modalities. TOF-MRA, time-of- flight-magnetic resonance angiography; CTA, CT angiography, MCA, middle cerebral artery.](ymj-59-80-g001){#F1}

![CBF maps after acetazolamide administration in each group are depicted, coinciding with those of Fig. 1, where group A revealing almost sufficient vascular response in the lesion side, whereas group C showing partly decreased in comparison with contralateral side. Note that CBF maps of group B revealed intensely decreased vascular response in comparison with other 2 groups. CBF, cerebral blood flow.](ymj-59-80-g002){#F2}

![Mean CBF values of 3 categorized groups (A, B, and C) at rest and after acetazolamide administration were revealed in left and right, respectively. There were no significant differences in both rest and acetazolamide challenge (left and right) among all groups. In respect to CBF values after acetazolamide challenge (right), only group B had significant difference compared with the value before acetazolamide administration (^\*^*p*\<0.05). CBF, cerebral blood flow.](ymj-59-80-g003){#F3}

![Mean CVRs in all categorized groups (A, B, and C) are shown. Mean CVR in group B was significantly lower than that in group A (^\*^*p*\<0.05); note that only the mean CVR in group B showed a negative value, which is regarded as a steal phenomenon. CVR: cerebrovascular response.](ymj-59-80-g004){#F4}

###### Case Summary of All 17 Cases

![](ymj-59-80-i001)

  Group   No.   Age        Sex       Disease   Symptoms          Ipsilateral infarction   MRA            CTA   
  ------- ----- ---------- --------- --------- ----------------- ------------------------ -------------- ----- ---
  A       1     65         F         R         ICAo              Headache                 (−)            1     1
  2       71    M          L         ICAo      Incidental        (−)                      1              1     
  3       62    M          L         ICAo      Rt.hemiparesis    (+)                      1              1     
  4       71    M          R         ICAo      Incidental        (−)                      1              1     
  5       79    F          R         ICAo      Dysarthria        (+)                      1              1     
  6       60    M          R         ICAo      Incidental        (−)                      1              1     
  B       7     66         F         R         MCAo              Dizzyness                (−)            0     1
  8       77    F          R         ICAo      Incidental        (−)                      0              1     
  9       76    M          R         MCAo      Lt. hemiparesis   (+)                      0              1     
  10      70    M          L         ICAo      Dizzyness         (−)                      0              1     
  11      81    F          R         ICAo      Incidental        (−)                      0              1     
  12      68    M          L         MCAo      Dizzyness         (+)                      0              1     
  C       13    63         F         L         MCAo              Headache                 (−)            0     0
  14      65    F          R         MCAo      Dizzyness         (−)                      0              0     
  15      71    F          L         MCAo      Incidental        (−)                      0              0     
  16      80    F          L         ICAo      Incidental        (−)                      0              0     
  17      60    M          L         MCAo      Dysarthria        (+)                      0              0     
                69.7±6.9   M:F=8:9   R:L=9:8   ICAo=10, MCAo=7                            (+):(−)=5:12         

MRA, magnetic resonance angiography; CTA, CT angiography; ICAo, internal carotid artery occlusion; MCAo, middle cerebral artery occlusion.

In the colum of MRA and CTA, (+) and (-) means delineation and no delineation of middle cerebral artery, respectively.
